Medical Care
Global In-vitro Inflammatory Bowel Disease Diagnostic Market Research Report 2025
- Jul 08, 25
- ID: 347511
- Pages: 75
- Figures: 80
- Views: 1
The global market for In-vitro Inflammatory Bowel Disease Diagnostic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual .Common symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In-vitro Inflammatory Bowel Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Inflammatory Bowel Disease Diagnostic.
The In-vitro Inflammatory Bowel Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-vitro Inflammatory Bowel Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-vitro Inflammatory Bowel Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
Segment by Type
Assays/Biomarker
Analyzers
Segment by Application
Diagnostic Laboratories
Hospitals
Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Inflammatory Bowel Disease Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual .Common symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In-vitro Inflammatory Bowel Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Inflammatory Bowel Disease Diagnostic.
The In-vitro Inflammatory Bowel Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-vitro Inflammatory Bowel Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-vitro Inflammatory Bowel Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
Segment by Type
Assays/Biomarker
Analyzers
Segment by Application
Diagnostic Laboratories
Hospitals
Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Inflammatory Bowel Disease Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assays/Biomarker
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Perspective (2020-2031)
2.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Growth Trends by Region
2.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Dynamics
2.3.1 In-vitro Inflammatory Bowel Disease Diagnostic Industry Trends
2.3.2 In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
2.3.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
2.3.4 In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue
3.1.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue (2020-2025)
3.1.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In-vitro Inflammatory Bowel Disease Diagnostic Revenue
3.4 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio
3.4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2024
3.5 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic Head office and Area Served
3.6 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Product and Application
3.7 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Type
4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2026-2031)
5 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Application
5.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
6.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025)
6.4 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
7.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025)
7.4 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
9.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025)
9.4 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DiaSorin S.p.A
11.1.1 DiaSorin S.p.A Company Details
11.1.2 DiaSorin S.p.A Business Overview
11.1.3 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.1.4 DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.1.5 DiaSorin S.p.A Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Company Details
11.3.2 Siemens Healthineers AG Business Overview
11.3.3 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.3.4 Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.3.5 Siemens Healthineers AG Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.4.4 Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.4.5 Abbott Recent Development
11.5 Quidel Corporation
11.5.1 Quidel Corporation Company Details
11.5.2 Quidel Corporation Business Overview
11.5.3 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.5.4 Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.5.5 Quidel Corporation Recent Development
11.6 American Laboratory Products Company (ALPCO)
11.6.1 American Laboratory Products Company (ALPCO) Company Details
11.6.2 American Laboratory Products Company (ALPCO) Business Overview
11.6.3 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.6.4 American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.6.5 American Laboratory Products Company (ALPCO) Recent Development
11.7 Certest Biotec SL.
11.7.1 Certest Biotec SL. Company Details
11.7.2 Certest Biotec SL. Business Overview
11.7.3 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.7.4 Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.7.5 Certest Biotec SL. Recent Development
11.8 Biosystems S.A.
11.8.1 Biosystems S.A. Company Details
11.8.2 Biosystems S.A. Business Overview
11.8.3 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.8.4 Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.8.5 Biosystems S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assays/Biomarker
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Perspective (2020-2031)
2.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Growth Trends by Region
2.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Dynamics
2.3.1 In-vitro Inflammatory Bowel Disease Diagnostic Industry Trends
2.3.2 In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
2.3.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
2.3.4 In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue
3.1.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue (2020-2025)
3.1.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In-vitro Inflammatory Bowel Disease Diagnostic Revenue
3.4 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio
3.4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2024
3.5 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic Head office and Area Served
3.6 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Product and Application
3.7 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Type
4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2026-2031)
5 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Application
5.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
6.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025)
6.4 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
7.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025)
7.4 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
9.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025)
9.4 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DiaSorin S.p.A
11.1.1 DiaSorin S.p.A Company Details
11.1.2 DiaSorin S.p.A Business Overview
11.1.3 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.1.4 DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.1.5 DiaSorin S.p.A Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Company Details
11.3.2 Siemens Healthineers AG Business Overview
11.3.3 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.3.4 Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.3.5 Siemens Healthineers AG Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.4.4 Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.4.5 Abbott Recent Development
11.5 Quidel Corporation
11.5.1 Quidel Corporation Company Details
11.5.2 Quidel Corporation Business Overview
11.5.3 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.5.4 Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.5.5 Quidel Corporation Recent Development
11.6 American Laboratory Products Company (ALPCO)
11.6.1 American Laboratory Products Company (ALPCO) Company Details
11.6.2 American Laboratory Products Company (ALPCO) Business Overview
11.6.3 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.6.4 American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.6.5 American Laboratory Products Company (ALPCO) Recent Development
11.7 Certest Biotec SL.
11.7.1 Certest Biotec SL. Company Details
11.7.2 Certest Biotec SL. Business Overview
11.7.3 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.7.4 Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.7.5 Certest Biotec SL. Recent Development
11.8 Biosystems S.A.
11.8.1 Biosystems S.A. Company Details
11.8.2 Biosystems S.A. Business Overview
11.8.3 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.8.4 Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
11.8.5 Biosystems S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Assays/Biomarker
Table 3. Key Players of Analyzers
Table 4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2020-2025)
Table 8. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2026-2031)
Table 10. In-vitro Inflammatory Bowel Disease Diagnostic Market Trends
Table 11. In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
Table 12. In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
Table 13. In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
Table 14. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Players (2020-2025)
Table 16. Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Inflammatory Bowel Disease Diagnostic as of 2024)
Table 17. Ranking of Global Top In-vitro Inflammatory Bowel Disease Diagnostic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Headquarters and Area Served
Table 20. Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Product and Application
Table 21. Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2020-2025)
Table 25. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2026-2031)
Table 27. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Application (2020-2025)
Table 29. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Application (2026-2031)
Table 31. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 46. DiaSorin S.p.A Company Details
Table 47. DiaSorin S.p.A Business Overview
Table 48. DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 49. DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 50. DiaSorin S.p.A Recent Development
Table 51. F. Hoffmann-La Roche Ltd Company Details
Table 52. F. Hoffmann-La Roche Ltd Business Overview
Table 53. F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 54. F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 55. F. Hoffmann-La Roche Ltd Recent Development
Table 56. Siemens Healthineers AG Company Details
Table 57. Siemens Healthineers AG Business Overview
Table 58. Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 59. Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 60. Siemens Healthineers AG Recent Development
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 64. Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Quidel Corporation Company Details
Table 67. Quidel Corporation Business Overview
Table 68. Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 69. Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 70. Quidel Corporation Recent Development
Table 71. American Laboratory Products Company (ALPCO) Company Details
Table 72. American Laboratory Products Company (ALPCO) Business Overview
Table 73. American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 74. American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 75. American Laboratory Products Company (ALPCO) Recent Development
Table 76. Certest Biotec SL. Company Details
Table 77. Certest Biotec SL. Business Overview
Table 78. Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 79. Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 80. Certest Biotec SL. Recent Development
Table 81. Biosystems S.A. Company Details
Table 82. Biosystems S.A. Business Overview
Table 83. Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 84. Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 85. Biosystems S.A. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. In-vitro Inflammatory Bowel Disease Diagnostic Picture
Figure 2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Assays/Biomarker Features
Figure 5. Analyzers Features
Figure 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application: 2024 VS 2031
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. In-vitro Inflammatory Bowel Disease Diagnostic Report Years Considered
Figure 12. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region: 2024 VS 2031
Figure 15. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Players in 2024
Figure 16. Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Inflammatory Bowel Disease Diagnostic as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2024
Figure 18. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2020-2031)
Figure 20. United States In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2020-2031)
Figure 24. Germany In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2020-2031)
Figure 32. China In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2020-2031)
Figure 40. Mexico In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2020-2031)
Figure 44. Turkey In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. DiaSorin S.p.A Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 48. F. Hoffmann-La Roche Ltd Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 49. Siemens Healthineers AG Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 51. Quidel Corporation Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 52. American Laboratory Products Company (ALPCO) Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 53. Certest Biotec SL. Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 54. Biosystems S.A. Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Assays/Biomarker
Table 3. Key Players of Analyzers
Table 4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2020-2025)
Table 8. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2026-2031)
Table 10. In-vitro Inflammatory Bowel Disease Diagnostic Market Trends
Table 11. In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
Table 12. In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
Table 13. In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
Table 14. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Players (2020-2025)
Table 16. Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Inflammatory Bowel Disease Diagnostic as of 2024)
Table 17. Ranking of Global Top In-vitro Inflammatory Bowel Disease Diagnostic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Headquarters and Area Served
Table 20. Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Product and Application
Table 21. Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2020-2025)
Table 25. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2026-2031)
Table 27. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Application (2020-2025)
Table 29. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Application (2026-2031)
Table 31. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 46. DiaSorin S.p.A Company Details
Table 47. DiaSorin S.p.A Business Overview
Table 48. DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 49. DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 50. DiaSorin S.p.A Recent Development
Table 51. F. Hoffmann-La Roche Ltd Company Details
Table 52. F. Hoffmann-La Roche Ltd Business Overview
Table 53. F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 54. F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 55. F. Hoffmann-La Roche Ltd Recent Development
Table 56. Siemens Healthineers AG Company Details
Table 57. Siemens Healthineers AG Business Overview
Table 58. Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 59. Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 60. Siemens Healthineers AG Recent Development
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 64. Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Quidel Corporation Company Details
Table 67. Quidel Corporation Business Overview
Table 68. Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 69. Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 70. Quidel Corporation Recent Development
Table 71. American Laboratory Products Company (ALPCO) Company Details
Table 72. American Laboratory Products Company (ALPCO) Business Overview
Table 73. American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 74. American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 75. American Laboratory Products Company (ALPCO) Recent Development
Table 76. Certest Biotec SL. Company Details
Table 77. Certest Biotec SL. Business Overview
Table 78. Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 79. Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 80. Certest Biotec SL. Recent Development
Table 81. Biosystems S.A. Company Details
Table 82. Biosystems S.A. Business Overview
Table 83. Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 84. Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 85. Biosystems S.A. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. In-vitro Inflammatory Bowel Disease Diagnostic Picture
Figure 2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Assays/Biomarker Features
Figure 5. Analyzers Features
Figure 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application: 2024 VS 2031
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. In-vitro Inflammatory Bowel Disease Diagnostic Report Years Considered
Figure 12. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region: 2024 VS 2031
Figure 15. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Players in 2024
Figure 16. Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Inflammatory Bowel Disease Diagnostic as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2024
Figure 18. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2020-2031)
Figure 20. United States In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2020-2031)
Figure 24. Germany In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2020-2031)
Figure 32. China In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2020-2031)
Figure 40. Mexico In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2020-2031)
Figure 44. Turkey In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. DiaSorin S.p.A Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 48. F. Hoffmann-La Roche Ltd Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 49. Siemens Healthineers AG Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 51. Quidel Corporation Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 52. American Laboratory Products Company (ALPCO) Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 53. Certest Biotec SL. Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 54. Biosystems S.A. Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232